We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laparoscopy Found Effective for Prostate Cancer

By HospiMedica staff writers
Posted on 16 Oct 2001
A study has found that laparoscopy is just as effective as traditional open radical prostatectomy in demonstrating immediate postoperative cancer control. More...
Conducted by surgeons at the University of Massachusetts Medical Center (UMMC, Worcester, USA), the findings were presented at the 2001 Clinical Congress of the American College of Surgeons in New Orleans (LA, USA).

Laparoscopic radical prostatectomy also requires a minimal number of blood transfusions. Another benefit of the laparoscopic method is better visualization of the operative field. The current study, involving 60 patients, follows on an earlier study that demonstrated no evidence of cancer at the margins of prostate tissue removed at surgery in 89% of 37 patients undergoing laparoscopy, compared to 68% of 37 men who underwent open surgery. Surgeons in the division of urology at the UMMC are currently performing the procedure on any man who is a suitable candidate, including those who have had prior abdominal or prostate surgery or hormone therapy, those with exceptionally enlarged prostate glands, and those who are obese.

"In general, our patients are able to go home sooner; in fact, it's not uncommon for them to go home the day following surgery,” noted Dr. Douglas Dahl, who led the research team. With the standard open prostatectomy in most high-volume hospitals, patients stay in the hospital two or three nights, so on average, we're saving one to two hospital days.”




Related Links:
American College of

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.